STAAR Surgical (STAA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
STAAR Surgical Reports First Quarter 2015 Results
April 29, 2015 4:01 PM EDTMONROVIA, Calif., April 29, 2015 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2015.
First Quarter Overview
Net Sales of $18.9 Million Decreased 7% from the Year Ago Period and 3% on a Constant Currency Basis ICL Units in North America Increased 18% and EMEA Units Increased 9% CentraFLOW® Accounted for 78% of ICL Shipments in China Gross Margin Increased to 68% in Q1 vs. 57% in Q4 2014... More